Smith & Nephew plc
NYSE: SNN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Deepak S. Nath
- Employees
- 17,349
- Headquarters
- Watford, United Kingdom
- IPO year
- 1999
- Market cap
- $12.7B
- Website
- https://www.smith-nephew.com
Loading SNN…
Loading profile data…Frequently asked questions about SNN
What does Smith & Nephew plc (SNN) do?
Smith & Nephew plc, along with its various subsidiary companies, operates globally in the research, development, manufacturing, marketing, and distribution of medical devices. The company's orthopedic reconstruction portfolio includes knee implants designed for total knee replacement surgeries and hip implants used in the reconstruction of hip j...
Where does SNN trade?
Smith & Nephew plc (SNN) trades on the New York Stock Exchange.
What sector is SNN in?
Smith & Nephew plc (SNN) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Smith & Nephew plc?
Deepak S. Nath is the chief executive officer of Smith & Nephew plc (SNN).
Where is Smith & Nephew plc headquartered?
Smith & Nephew plc is headquartered in United Kingdom.
Does SNN pay a dividend?
Yes — Smith & Nephew plc (SNN) paid a trailing twelve-month dividend of USD 0.78 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SNN go public?
Smith & Nephew plc (SNN) completed its initial public offering in 1999.
Is SNN an ADR?
Yes — SNN is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Smith & Nephew plc reporting and dividends follow the underlying issuer.